These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 14645687)
1. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding. Figler H; Olsson RA; Linden J Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687 [TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain. Childers SR; Li X; Xiao R; Eisenach JC J Neurochem; 2005 May; 93(3):715-23. PubMed ID: 15836630 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor. Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659 [TBL] [Abstract][Full Text] [Related]
4. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor. Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101 [TBL] [Abstract][Full Text] [Related]
5. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors. Bhattacharya S; Linden J Mol Pharmacol; 1996 Jul; 50(1):104-11. PubMed ID: 8700102 [TBL] [Abstract][Full Text] [Related]
6. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816 [TBL] [Abstract][Full Text] [Related]
7. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures. Siehler S; Nunn C; Zupanc GK; Hoyer D Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149 [TBL] [Abstract][Full Text] [Related]
8. Allosteric interactions between the binding sites of receptor agonists and guanine nucleotides: a comparative study of the 5-hydroxytryptamine1A and adenosine A1 receptor systems in rat hippocampal membranes. Mahle CD; Wiener HL; Yocca FD; Maayani S J Pharmacol Exp Ther; 1992 Dec; 263(3):1275-84. PubMed ID: 1469633 [TBL] [Abstract][Full Text] [Related]
9. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells. Witt-Enderby PA; Dubocovich ML Mol Pharmacol; 1996 Jul; 50(1):166-74. PubMed ID: 8700109 [TBL] [Abstract][Full Text] [Related]
10. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723. Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544 [TBL] [Abstract][Full Text] [Related]
11. The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with Gs. Bhattacharya S; Youkey RL; Ghartey K; Leonard M; Linden J; Tucker AL Biochem J; 2006 May; 396(1):139-46. PubMed ID: 16390330 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer. Baraldi PG; Pavani MG; Leung E; Moorman AR; Varani K; Vincenzi F; Borea PA; Romagnoli R Bioorg Med Chem Lett; 2006 Mar; 16(5):1402-4. PubMed ID: 16321527 [TBL] [Abstract][Full Text] [Related]
13. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label. Patel A; Craig RH; Daluge SM; Linden J Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075 [TBL] [Abstract][Full Text] [Related]
14. Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor. Leid M; Schimerlik MI; Murray TF Mol Pharmacol; 1989 Apr; 35(4):450-7. PubMed ID: 2495433 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptor. Baraldi PG; Pavani MG; Shryock JC; Moorman AR; Iannotta V; Borea PA; Romagnoli R Eur J Med Chem; 2004 Oct; 39(10):855-65. PubMed ID: 15464619 [TBL] [Abstract][Full Text] [Related]
16. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor. Heitman LH; Ye K; Oosterom J; Ijzerman AP Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315 [TBL] [Abstract][Full Text] [Related]
17. The allosteric enhancer, PD 81,723, stabilizes human A1 adenosine receptor coupling to G proteins. Bhattacharya S; Linden J Biochim Biophys Acta; 1995 Feb; 1265(1):15-21. PubMed ID: 7857979 [TBL] [Abstract][Full Text] [Related]
18. Enhancer and competitive allosteric modulation model for G-protein-coupled receptors. Pietra D; Borghini A; Breschi MC; Bianucci AM J Theor Biol; 2010 Dec; 267(4):663-75. PubMed ID: 20800599 [TBL] [Abstract][Full Text] [Related]
19. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation. Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030 [TBL] [Abstract][Full Text] [Related]
20. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors. Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]